Laboratorios Farmaceuticos Rovi (MEX:ROVIN) Cyclically Adjusted Book per Share: MXN178.40 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ROVIN Laboratorios Farmaceuticos Rovi SA MEX:ROVIN
81 GF Score
Price MXN1,168.82
GF Value MXN1,103.32
! 2 Warning Signs
View Full Analysis

What is Laboratorios Farmaceuticos Rovi Cyclically Adjusted Book per Share?

Laboratorios Farmaceuticos Rovi MEX:ROVIN 81 Cyclically Adjusted Book per Share is MXN178.40 as of Jun. 2026. GuruFocus rates MEX:ROVIN with a GF Score™ of 81/100 and a GF Value™ of MXN1,103.32. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Laboratorios Farmaceuticos Rovi's adjusted book value per share for the three months ended in Jun. 2026 was MXN275.389. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN178.40 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Laboratorios Farmaceuticos Rovi's average Cyclically Adjusted Book Growth Rate was 13.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 14.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Laboratorios Farmaceuticos Rovi was 18.20% per year. The lowest was 14.40% per year. And the median was 15.60% per year.

As of today (2026-08-09), Laboratorios Farmaceuticos Rovi's current stock price is MXN1168.82. Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN178.40. Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio of today is 6.55.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Laboratorios Farmaceuticos Rovi was 16.48. The lowest was 5.54. And the median was 8.23.


Laboratorios Farmaceuticos Rovi  (MEX:ROVIN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1168.82/178.40
=6.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Laboratorios Farmaceuticos Rovi was 16.48. The lowest was 5.54. And the median was 8.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Laboratorios Farmaceuticos Rovi Cyclically Adjusted Book per Share Related Terms


Laboratorios Farmaceuticos Rovi Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi Cyclically Adjusted Book per Share Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.18 112.73 110.02 149.84 153.79

Laboratorios Farmaceuticos Rovi Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.98 158.76 153.79 174.91 178.40

MEX:ROVIN vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio falls into.


MEX:ROVIN
81GF Score
Laboratorios Farmaceuticos Rovi SA MEX:ROVIN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorios Farmaceuticos Rovi Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laboratorios Farmaceuticos Rovi's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=275.389/131.3300*131.3300
=275.389

Current CPI (Jun. 2026) = 131.3300.

Laboratorios Farmaceuticos Rovi Quarterly Data

Book Value per Share CPI Adj_Book
201609 78.827 99.737 103.797
201612 80.936 101.842 104.371
201703 77.648 100.896 101.069
201706 78.298 101.848 100.963
201709 83.973 101.524 108.626
201712 90.342 102.975 115.219
201803 90.215 102.122 116.018
201806 89.901 104.165 113.347
201809 89.023 103.818 112.614
201812 115.966 104.193 146.169
201903 116.534 103.488 147.886
201906 117.303 104.612 147.263
201909 123.201 103.905 155.719
201912 121.985 105.015 152.553
202003 157.306 103.469 199.664
202006 165.291 104.254 208.218
202009 173.544 103.521 220.164
202012 163.252 104.456 205.253
202103 174.559 104.857 218.629
202106 174.832 107.102 214.381
202109 197.918 107.669 241.413
202112 199.158 111.298 235.004
202203 173.101 115.153 197.419
202206 158.984 118.044 176.877
202209 171.490 117.221 192.131
202212 205.063 117.650 228.907
202303 209.051 118.948 230.813
202306 179.805 120.278 196.326
202309 193.413 121.343 209.332
202312 192.675 121.300 208.607
202403 182.760 122.762 195.515
202406 183.555 124.409 193.767
202409 234.410 123.121 250.040
202412 244.231 124.753 257.106
202503 255.083 125.531 266.868
202506 239.317 127.251 246.989
202509 261.715 126.840 270.979
202512 273.876 128.400 280.126
202603 274.667 129.860 277.776
202606 275.389 131.330 275.389

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN178.40 mean?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a Cyclically Adjusted Book per Share of MXN178.40 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Laboratorios Farmaceuticos Rovi and its competitors.
Is Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share too high?
Laboratorios Farmaceuticos Rovi's current Cyclically Adjusted Book per Share is MXN178.40. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share of MXN178.40 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current Cyclically Adjusted Book per Share is MXN178.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Laboratorios Farmaceuticos Rovi (MEX:ROVIN) has a current Cyclically Adjusted Book per Share of MXN178.40. The stock's GF Value™ is MXN1,103.32, compared to a current price of MXN1,168.82 — trading 5.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is MXN178.40. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (MEX:ROVIN), the current Cyclically Adjusted Book per Share is MXN178.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (MEX:ROVIN) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of MXN1,168.82 is trading 5.9% above its estimated GF Value™ of MXN1,103.32.

Key valuation signals for MEX:ROVIN:

  • Cyclically Adjusted Book per Share: MXN178.40
  • GF Value™: MXN1,103.32 vs. price of MXN1,168.82 (5.9% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the MEX:ROVIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorios Farmaceuticos Rovi Business Description

Address Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
81GF Score

Get the complete analysis for MEX:ROVIN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,168.82
Price
MXN1,103.32
GF Value